CustomCustomCustomCustomCustomCustom

home2025-02-22T10:49:36+01:00

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

TAmiRNA - stability for live

Our Expertise:
RNA signatures and diagnostics

mircoRNA_signatures

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

TAmiRNA - stability for live

Our Focus:
biomarker discovery for complex diseases

age_associated_diseases

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

TAmiRNA - stability for live

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

Our Focus:
biomarker discovery for complex diseases

mircoRNA_signatures

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

Our Expertise:
RNA signatures and diagnostics

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

Services

Transcriptomic services

services

Exploring microRNAs, mRNAs, circular RNAs, or other non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) and untargeted (NGS-based) RNA analysis in serum, plasma, urine, saliva, milk, EVs, exosomes, cells, and tissues. With 11+ years of RNA biomarker expertise, we ensure reliable results and project success.

TAmiRNA - the power of microRNA biomarkers

RNA biomarker services

Interested in our microRNA disease panels or IVD/RUO kits but lack the time or resources for in-house analysis?

Send us your samples, and our in-house services will deliver results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, and thrombomiR®. We also support custom miRNA or mRNA signature analysis by implementing tailored workflows.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

our services

RNA analysis services

services

You are interested in microRNAs, mRNAs, circular RNAs, as well as other small or long non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) as well as untargeted (transcriptomic) analysis of any RNA in serum, plasma, urine, saliva, EVs and exosomes, cells, and tissues. Our experience of 11+ years in RNA biomarker development ensure the success of our customer projects.

TAmiRNA - the power of microRNA biomarkers

Kit services

You are interested in our microRNA disease panels or IVD/RUO kits, but don´t have the time or resources to analyse in your lab?

You can send us your samples to obtain results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, or thrombomiR® by taking advantage of our in-house services. In addition, we can support the analysis of your specific miRNA or mRNA signature by implementing a tailored workflow or kit.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

Products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

latest news

TAmiRNA and Medical University of Vienna Advance Liver Surgery Safety with hepatomiR®

By |February 20th, 2025|Categories: biomarker, biomarkers, CE-IVD, hepatomiR kit, Liver disease, microRNAs, MUW, Personalized medicine, smallRNA|Tags: , , , , , |

TAmiRNA has joined forces with the Medical University of Vienna to develop an innovative microRNA test (hepatomiR®) to improve safety in liver surgery. The pioneering qPCR-based test is founded [...]

Read More
 0

7Bioscience and TAmiRNA collaborate to expand access to our cutting-edge transcriptomics services

By |February 5th, 2025|Categories: biomarker, biomarkers, microRNA services, microRNAs, sequencing, smallRNA|Tags: , , , , , |

We are delighted to welcome 7Bioscience as the new distribution partner of TAmiRNA GmbH! With a strong track record in clinical and research molecular biology, 7Bioscience will support to [...]

Read More
Comments Off on 7Bioscience and TAmiRNA collaborate to expand access to our cutting-edge transcriptomics services

TAmiRNA ‘2024 In Review’

By |January 9th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, CE-IVD, congress, EVscale, exosomes, extracellular vesicle, hepatomiR kit, Illumina NewSeq2000, ISO 13485, liquid biopsies, Liver disease, microRNA, microRNA services, microRNAs, NGS, PCR testing service, quality, sequencing, small RNA-sequencing, smallRNA, test service|Tags: , , , , , , , , , , , , |

2024: A Year of Growth, Innovation, and Collaboration 2024 has come to a close. We are proud to reflect on the milestones and achievements we’ve reached together with our [...]

Read More
Comments Off on TAmiRNA ‘2024 In Review’

TAmiRNA and Medical University of Vienna Advance Liver Surgery Safety with hepatomiR®

By |February 20th, 2025|Categories: biomarker, biomarkers, CE-IVD, hepatomiR kit, Liver disease, microRNAs, MUW, Personalized medicine, smallRNA|Tags: , , , , , |

TAmiRNA has joined forces with the Medical University of Vienna to develop an innovative microRNA test (hepatomiR®) to improve safety in liver surgery. The pioneering qPCR-based test is founded on original research [...]

Read More
 0

7Bioscience and TAmiRNA collaborate to expand access to our cutting-edge transcriptomics services

By |February 5th, 2025|Categories: biomarker, biomarkers, microRNA services, microRNAs, sequencing, smallRNA|Tags: , , , , , |

We are delighted to welcome 7Bioscience as the new distribution partner of TAmiRNA GmbH! With a strong track record in clinical and research molecular biology, 7Bioscience will support to offer TAmiRNA’s innovative [...]

Read More
Comments Off on 7Bioscience and TAmiRNA collaborate to expand access to our cutting-edge transcriptomics services

TAmiRNA ‘2024 In Review’

By |January 9th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, CE-IVD, congress, EVscale, exosomes, extracellular vesicle, hepatomiR kit, Illumina NewSeq2000, ISO 13485, liquid biopsies, Liver disease, microRNA, microRNA services, microRNAs, NGS, PCR testing service, quality, sequencing, small RNA-sequencing, smallRNA, test service|Tags: , , , , , , , , , , , , |

2024: A Year of Growth, Innovation, and Collaboration 2024 has come to a close. We are proud to reflect on the milestones and achievements we’ve reached together with our incredible team, customers, [...]

Read More
Comments Off on TAmiRNA ‘2024 In Review’
© Copyright TAmiRNA 2019 - 
 
Go to Top